Tue, March 28, 2023

Andreas Argyrides Maintained (UBX) at Buy with Decreased Target to $5 on, Mar 28th, 2023

Andreas Argyrides of Wedbush, Maintained "Unity Biotechnology, Inc." (UBX) at Buy with Decreased Target from $35 to $5 on, Mar 28th, 2023.

Andreas has made no other calls on UBX in the last 4 months.



There is 1 other peer that has a rating on UBX. Out of the 1 peers that are also analyzing UBX, 0 agree with Andreas's Rating of Hold.



This is the rating of the analyst that currently disagrees with Andreas


  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $10 on, Thursday, March 16th, 2023